98 related articles for article (PubMed ID: 8544593)
1. The effect of botulinum toxin type A injection on compound muscle action potential in an in vivo rat model.
Cichon JV; McCaffrey TV; Litchy WJ; Knops JL
Laryngoscope; 1995 Feb; 105(2):144-8. PubMed ID: 8544593
[TBL] [Abstract][Full Text] [Related]
2. Quantitative determination of the biological activity of botulinum toxin type A by measuring the compound muscle action potential (CMAP) in rats.
Sakamoto T; Torii Y; Takahashi M; Ishida S; Goto Y; Nakano H; Harakawa T; Ginnaga A; Kozaki S; Kaji R
Toxicon; 2009 Nov; 54(6):857-61. PubMed ID: 19559720
[TBL] [Abstract][Full Text] [Related]
3. Different types of botulinum toxin in humans.
Eleopra R; Tugnoli V; Quatrale R; Rossetto O; Montecucco C
Mov Disord; 2004 Mar; 19 Suppl 8():S53-9. PubMed ID: 15027055
[TBL] [Abstract][Full Text] [Related]
4. Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins.
Torii Y; Goto Y; Takahashi M; Ishida S; Harakawa T; Sakamoto T; Kaji R; Kozaki S; Ginnaga A
Toxicon; 2010; 55(2-3):407-14. PubMed ID: 19778548
[TBL] [Abstract][Full Text] [Related]
5. Increased electrotonic coupling in spinal motoneurons after transient botulinum neurotoxin paralysis in the neonatal rat.
Pastor AM; Mentis GZ; De La Cruz RR; Díaz E; Navarrete R
J Neurophysiol; 2003 Feb; 89(2):793-805. PubMed ID: 12574457
[TBL] [Abstract][Full Text] [Related]
6. Nerve stimulation boosts botulinum toxin action in spasticity.
Frasson E; Priori A; Ruzzante B; Didonè G; Bertolasi L
Mov Disord; 2005 May; 20(5):624-9. PubMed ID: 15726575
[TBL] [Abstract][Full Text] [Related]
7. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.
Shaari CM; Sanders I
Muscle Nerve; 1993 Sep; 16(9):964-9. PubMed ID: 8355728
[TBL] [Abstract][Full Text] [Related]
8. Effects of treadmill running on rat gastrocnemius function following botulinum toxin A injection.
Tsai SW; Chen CJ; Chen HL; Chen CM; Chang YY
J Orthop Res; 2012 Feb; 30(2):319-24. PubMed ID: 21815203
[TBL] [Abstract][Full Text] [Related]
9. Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential (CMAP).
Torii Y; Takahashi M; Ishida S; Goto Y; Nakahira S; Harakawa T; Kaji R; Kozaki S; Ginnaga A
Toxicon; 2010; 55(2-3):662-5. PubMed ID: 19781565
[TBL] [Abstract][Full Text] [Related]
10. Comparison of neuromuscular blockade and recovery with botulinum toxins A and F.
Billante CR; Zealear DL; Billante M; Reyes JH; Sant'Anna G; Rodriguez R; Stone RE
Muscle Nerve; 2002 Sep; 26(3):395-403. PubMed ID: 12210370
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
Fève A; Decq P; Filipetti P; Kéravel Y
Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study.
Smuts JA; Schultz D; Barnard A
Headache; 2004 Sep; 44(8):801-5. PubMed ID: 15330827
[TBL] [Abstract][Full Text] [Related]
13. Effects of Botox and Neuronox on muscle force generation in mice.
Stone AV; Ma J; Whitlock PW; Koman LA; Smith TL; Smith BP; Callahan MF
J Orthop Res; 2007 Dec; 25(12):1658-64. PubMed ID: 17600825
[TBL] [Abstract][Full Text] [Related]
14. The in vivo rat muscle force model is a reliable and clinically relevant test of consistency among botulinum toxin preparations.
Pickett A; O'Keeffe R; Judge A; Dodd S
Toxicon; 2008 Sep; 52(3):455-64. PubMed ID: 18639570
[TBL] [Abstract][Full Text] [Related]
15. [Qualitative analysis on the denervating action of botulinum toxin A in gel].
Chen JC; Mai GH; Yu XP; Yu HY; Wu HP; Jiang FT
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):104-7. PubMed ID: 21141570
[TBL] [Abstract][Full Text] [Related]
16. Sustained focal effects of low-dose intramuscular succinylcholine.
Walker FO; Scott GE; Butterworth J
Muscle Nerve; 1993 Feb; 16(2):181-7. PubMed ID: 8429843
[TBL] [Abstract][Full Text] [Related]
17. Serial neurophysiological studies of intramuscular botulinum-A toxin in humans.
Hamjian JA; Walker FO
Muscle Nerve; 1994 Dec; 17(12):1385-92. PubMed ID: 7969239
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of therapeutic botulinum toxin preparations.
Dressler D; Benecke R
Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
[TBL] [Abstract][Full Text] [Related]
19. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections.
Borodic GE; Ferrante R; Pearce LB; Smith K
Mov Disord; 1994 Jan; 9(1):31-9. PubMed ID: 8139603
[TBL] [Abstract][Full Text] [Related]
20. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans.
Eleopra R; Tugnoli V; De Grandis D
Mov Disord; 1997 Jan; 12(1):89-94. PubMed ID: 8990059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
